Insider Transactions in Q1 2021 at Kala Pharmaceuticals, Inc. (KALA)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2021
|
Hongming Chen CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9,500
+3.76%
|
$19,000
$2.3 P/Share
|
|
Feb 25
2021
|
Hongming Chen CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
47,000
+16.75%
|
$94,000
$2.3 P/Share
|
|
Jan 04
2021
|
Mary Reumuth CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
22,666
+13.28%
|
-
|
|
Jan 04
2021
|
Mark T Iwicki CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
76,000
+20.01%
|
-
|
|
Jan 04
2021
|
Todd Bazemore |
BUY
Grant, award, or other acquisition
|
Direct |
27,500
+16.67%
|
-
|
|
Jan 04
2021
|
Eric Trachtenberg |
BUY
Grant, award, or other acquisition
|
Direct |
22,666
+14.99%
|
-
|
|
Jan 04
2021
|
Hongming Chen CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
22,666
+10.84%
|
-
|
|
Jan 04
2021
|
Romulus K Brazzell |
BUY
Grant, award, or other acquisition
|
Direct |
27,500
+8.3%
|
-
|